BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Metabolic dysfunction-associated fatty liver disease
1
Beyond biomarkers: An integrated traditional Chinese medicine-machine learning approach predicts hepatic steatosis in high metabolic risk populations
10/14/2025 7:41:44 AM | Browse: 131 | Download: 295
2
Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies
8/27/2025 9:21:12 AM | Browse: 269 | Download: 510
3
Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease
7/24/2025 7:47:21 AM | Browse: 116 | Download: 304
4
Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study
6/26/2025 7:27:57 AM | Browse: 154 | Download: 851
5
Correlation between gynecomastia and endocrine regulation in patients with metabolic dysfunction-associated fatty liver disease: A cross-sectional study
6/26/2025 7:27:56 AM | Browse: 227 | Download: 856
6
Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis
5/27/2025 7:04:46 AM | Browse: 121 | Download: 611
7
Rethinking carnitine palmitoyltransferase-II and liver stem cells in metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma
4/18/2025 7:43:21 AM | Browse: 206 | Download: 495
8
Carnitine palmitoyltransferase-II inactivity promotes malignant progression of metabolic dysfunction-associated fatty liver disease via liver cancer stem cell activation
11/26/2024 7:20:29 AM | Browse: 178 | Download: 848
9
Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease
11/26/2024 7:20:28 AM | Browse: 205 | Download: 589
10
Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease?
10/25/2024 2:40:46 AM | Browse: 211 | Download: 733
11
Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
7/26/2024 10:33:29 AM | Browse: 232 | Download: 934
12
Exploring non-invasive diagnostics for metabolic dysfunction-associated fatty liver disease
7/24/2024 6:41:09 AM | Browse: 220 | Download: 712
13
Novel insights into autophagy in gastrointestinal pathologies, mechanisms in metabolic dysfunction-associated fatty liver disease and acute liver failure
7/11/2024 8:47:17 AM | Browse: 260 | Download: 785
14
Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease
7/1/2024 7:39:37 AM | Browse: 327 | Download: 1033
15
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker !
6/25/2024 10:41:21 AM | Browse: 287 | Download: 906
16
Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease
6/21/2024 3:14:32 AM | Browse: 211 | Download: 753
17
Screening for metabolic-dysfunction associated fatty liver disease: Time to discard the emperor's clothes of normal liver enzymes?
6/6/2024 5:43:14 AM | Browse: 263 | Download: 909
18
Update in lean metabolic dysfunction-associated steatotic liver disease
3/27/2024 1:28:19 PM | Browse: 251 | Download: 863
19
Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19
3/21/2024 11:37:41 AM | Browse: 339 | Download: 922
20
Predictive value of angiopoietin-like protein 8 in metabolic dysfunction-associated fatty liver disease and its progression: A case-control study
3/15/2024 9:49:52 AM | Browse: 416 | Download: 1250
21
Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China
3/14/2024 5:31:16 PM | Browse: 383 | Download: 1350
22
Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions
3/6/2024 6:10:51 AM | Browse: 371 | Download: 942
23
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
12/25/2023 6:03:15 AM | Browse: 384 | Download: 1203
24
Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study
12/1/2023 6:03:41 AM | Browse: 329 | Download: 1664
25
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023)
9/25/2023 9:07:43 AM | Browse: 525 | Download: 1404
26
Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
8/22/2023 7:39:26 AM | Browse: 393 | Download: 1607
27
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations
10/18/2022 8:29:59 AM | Browse: 820 | Download: 1505
28
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
9/9/2022 12:48:14 PM | Browse: 689 | Download: 1505
29
Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
2/22/2022 9:25:37 AM | Browse: 856 | Download: 2000
30
Nonalcoholic fatty liver disease shows significant sex dimorphism
2/11/2022 5:55:19 AM | Browse: 688 | Download: 1899
31
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
12/27/2021 5:24:00 AM | Browse: 847 | Download: 1682
32
Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis
7/23/2021 8:10:13 AM | Browse: 821 | Download: 2662
33
Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease
5/13/2021 10:05:39 AM | Browse: 808 | Download: 2178
34
COVID-19 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
4/21/2021 5:56:26 AM | Browse: 951 | Download: 1947
35
Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic-Chinese population
12/18/2020 5:58:43 AM | Browse: 1000 | Download: 2630
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.